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AbstrACt
Introduction Preterm birth has major medical, 
psychological and socioeconomic consequences 
worldwide. Music therapy (MT) has positive effects on 
physiological measures of preterm infants and maternal 
anxiety, but rigorous studies including long-term follow-up 
are missing. Drawing on caregivers’ inherent resources, 
this study emphasises caregiver involvement in MT to 
promote attuned, developmentally appropriate musical 
interactions that may be of mutual benefit to infant and 
parent. This study will determine whether MT, as delivered 
by a qualified music therapist during neonatal intensive 
care unit (NICU) hospitalisation and/or in home/municipal 
settings following discharge, is superior to standard care 
in improving bonding between primary caregivers and 
preterm infants, parent well-being and infant development.
Methods and analysis Design: international multicentre, 
assessor-blind, 2×2 factorial, pragmatic randomised 
controlled trial; informed by a completed feasibility study. 
Participants: 250 preterm infants and their parents. 
Intervention: MT focusing on parental singing specifically 
tailored to infant responses, will be delivered during NICU 
and/or during a postdischarge 6-month period. Primary 
outcome: changes in mother–infant bonding at 6-month 
corrected age (CA), as measured by the Postpartum 
Bonding Questionnaire. Secondary outcomes: mother–
infant bonding at discharge and at 12-month CA; child 
development over 24 months; and parental depression, 
anxiety and stress, and infant rehospitalisation, all over 12 
months.
Ethics and dissemination The Regional Committees for 
Medical and Health Research Ethics approved the study 
(2018/994/REK Nord, 03 July 2018). Service users were 
involved in development of the study and will be involved 
in implementation and dissemination. Dissemination of 
findings will apply to local, national and international 
levels.
trial registration number NCT03564184
bACkground
The global average rate of preterm birth is 
around 11% worldwide corresponding to 
15 million preterm infants each year.1 2 Over 
one million die as a direct result of prematurity, 
and another million show lifetime impair-
ments.3 With improved survival rates, there 
is growing concern for long-lasting compli-
cations including mental health problems, 
cognitive impairments and poorer quality 
of life.1 4–6 Moreover, the economic burden 
of preterm birth includes increased cost of 
neonatal care, long-term costs associated with 
complex health status, and losses in economic 
productivity over the lifespan.7
Premature labour is perceived as a stressful8 
and traumatic9 10 event that can interrupt 
mothers’ antenatal bonding.11 Families of 
premature infants can experience higher 
levels of stress, anxiety and fear for the infant’s 
safety, as well as insecurity and powerless-
ness.10 12 Mothers are at risk for postpartum 
depression, post-traumatic stress disorder, 
feelings of guilt, mourning and lack of self-
worth.13 Fathers experience significant stress, 
which may extend beyond the acute phase 
following the infant’s birth.14 Supportive 
and educational interventions provided to 
strengths and limitations of this study
 ► Following several studies suggesting short-term ef-
fects of music therapy (MT) for premature infants, 
this study will examine longer-term effects up to 
2 years.
 ► Parents will be actively included in MT, with the aim 
of improving outcomes of both infants and parents.
 ► MT will be continued after discharge from hospital, 
thus providing a bridge between specialised and pri-
mary healthcare.
 ► As a multinational trial, results will be relevant 
across a range of settings in diverse societies that 
enable social support from families.
 ► Due to the nature of the intervention, participants 
cannot be blinded. Similarly, most outcomes cannot 
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fathers in the acute phase of the infant’s hospitalisation 
can empower their fathering ability and reduce paternal 
stress.15
Separation due to neonatal intensive care unit (NICU) 
stay and prolonged hospitalisation may complicate the 
development of healthy parent–infant bonding and in 
some cases adversely impact the formation of secure 
attachment.10 16 Mother–infant relationship plays a central 
role in the child’s socioemotional development and 
formation of future intimate relationships.17 18 Mothers’ 
psychological well-being19 or postpartum depression20 
are important factors affecting parent–infant relation-
ship in the postnatal period. However, even with sensitive 
parenting, children born very preterm or very low birth 
weight are at higher risk of demonstrating disorganised 
attachment than those born full-term, and neurological 
impairment predicts this disorganised attachment.21 
Involving fathers in infant care, including skin-to-skin 
care, during the first days of the infant’s life can positively 
impact the bonding process while improving support to 
partners,22 and can lead to improved self-esteem, feelings 
of closeness to the infant and perception of more equal 
parenthood.23 Decreasing maternal stress and reducing 
early separation during NICU hospitalisation may be 
beneficial for long-term outcomes.24
Music therapy (MT) is part of NICU standard treatment 
in some hospitals in several countries, but supply is usually 
limited even where that is the case. MT in infant critical 
care involves the informed use of music and a therapeutic 
relationship to promote infant development and facil-
itate bonding with primary caregivers.25 MT promotes 
infant sensory regulation and may contribute to neuro-
logical development.26 27 Incorporating parents as active 
partners in implementing MT during the NICU stay leads 
to decreased infant and parent distress,28 and may thus 
promote bonding.29 MT beneficially impacts infant phys-
iological parameters, behaviour state, weight gain and 
feeding ability, and may reduce hospital stay.26 30–34 There 
are also some indications of a positive impact of music on 
sleep for premature infants.31 35 36 MT provides a cultur-
ally sensitive form of family centred care that empowers 
both mothers and fathers in the care of their premature 
infants.29 MT-based consult-to-parent models, such as 
the Time Together adaptation of contingent singing into a 
parent education programme, can help extend benefits 
to families beyond those most prioritised to receive MT 
services.37
In a rigorous systematic review and meta-analysis of 
randomised controlled trials (RCTs), a large and favour-
able effect of MT on respiratory rate and maternal 
anxiety was confirmed38; however, several areas require 
further investigation. Rigorously designed and adequately 
powered studies using standardised outcome measures 
and interventions implemented by music therapists with 
specialised NICU training are required. Parallel RCTs to 
evaluate long-term effects of MT, and extending inter-
vention periods past discharge from NICU, are required 
to assess long-term impact, which is a substantial gap in 
present knowledge.38 Studies examining longitudinal 
provision of MT tailored to different stages of infant 
development28 and long-term effects of MT on the devel-
opment of healthy parent–infant bonding and secure 
attachment are needed.26 38
Building on promising results from phase II studies and 
meta-analyses, Longitudinal Study of music Therapy’s 
Effectiveness for Premature infants and their caregivers 
(LongSTEP) is the first phase III trial worldwide of MT’s 
effectiveness for premature infants and their caregivers. 
This trial will determine whether MT as delivered by a 
qualified music therapist during NICU hospitalisation 
and/or after discharge to home is superior to standard 
care in improving bonding between primary caregivers 
and preterm infants. This project promotes continuity 
of care by bridging the transition from hospital to home 
and uses family centred developmental care. Conducting 
the study in several countries with high levels of parental 
presence in the NICU, provides sufficient sample size 
to analyse treatment effects. The results will inform the 
effective use of MT across levels of healthcare for the 
participating NICUs in Europe, the Middle East and 
South America. This study will contribute to an improved 
understanding of the relation between music and health 
and will enable evidence-based recommendations for the 
application of MT in primary healthcare services.
objectives
The primary objective of this study is to evaluate the effect 
of MT on parent–infant bonding at 6-month CA.
Secondary objectives are as follows:
1. To examine effects of MT on premature infants’ gener-
al and socioemotional development.
2. To examine effects of MT on parents’ symptoms of de-
pression, anxiety and stress.
3. To examine medical and social factors of premature in-
fants (sex, gestational age at birth, hearing status) and 
their parents (bonding, socioeconomic status, breast-
feeding, skin-to-skin care) that may be associated with 
effects of MT.
4. To prepare for examining cost-effectiveness and lon-
ger-term evaluation of effects.
We hypothesise that MT plus standard care during or 
after NICU, compared with standard care alone, will lead 
to better parent–infant bonding, which in turn may bene-
ficially impact infant development and parent mental 
health outcomes. Effects of MT may depend on medical 
and social factors. Clinical effectiveness may be associated 




LongSTEP is designed as a 2×2 factorial, international, 
multicentre, assessor-blind pragmatic RCT to evaluate the 
long-term effect of MT in NICU and/or after discharge 
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Figure 1 Flow of participants through the study: illustration of the study design. Note: ASQ-3, Ages and Stages Questionnaire 
(third edition); ASQ:SE-2, Ages and Stages Questionnaire: Social-Emotional (second edition); Bayley-III, Bayley Scales of Infant 
and Toddler Development (third edition); CA, corrected age (chronological age reduced by number of weeks born preterm); 
EPDS, Edinburgh Postnatal Depression Scale; GAD-7, Generalised Anxiety Disorder Assessment; PBQ, Postpartum Bonding 
Questionnaire; PSS, Parental Stress Scale.
a 12-month time period (figure 1). The factorial design 
entails a two-phase protocol covering both the stay in the 
NICU and follow-up care after discharge from hospital, 
with two randomisation time points, and tests the indepen-
dent effect of each combination: NICU-MT, postdischarge 
MT, both, or neither, as well as interactions between them.
Patient and public involvement
Parents of premature infants, hereafter referred to as 
‘users’, play an important role in various aspects of this 
study. We consulted with users during original develop-
ment of the project proposal to assure that our research 
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infants, to estimate level of burden of the intervention 
and to assess if the intervention is likely to result in bene-
fits that would be of value to users. We incorporated feed-
back from users in protocol development, both before 
and after securing funding. We developed a User Advi-
sory Group (UAG) to advise us on selection of outcome 
measures, feasibility of study design and intervention 
implementation, and this group will continue to serve an 
important role during the implementation of the study 
as described in the section on advisory committees. We 
will disseminate results of the study to users via popular 
publications, presentations to parent organisations and 
informational pamphlets with recommendations for 
evidence-based practices.
Pilot testing and user feedback
A feasibility study was conducted at one Norwegian NICU 
(initiated January 2018) to determine acceptability and 
suitability of the intervention and study procedures and 
to obtain parental perspectives in order to inform design 
of the main study. Pilot testing evaluated feasibility in 
the areas of participant recruitment, delivery of study 
conditions, planned assessments and retention, as well as 
tracking of treatment occurring as part of standard care. 
Following ethics approval, three families at a Norwegian 
NICU were offered MT two times per week during NICU 
hospitalisation and two times per month during the first 
3 months after discharge home. Follow-up interviews with 
parents revealed that parents were willing to take part 
in MT in the NICU and sing for their infants, and that 
MT offered a break from typical hospital routines and a 
different way of ‘reading’ and relating to their infants. 
Parents found the self-report outcome measures accept-
able and the nature of participation in MT as well as the 
frequency of sessions feasible and comfortable. Parents 
stated they would also have been willing to participate in 
the study if designed as an RCT despite the chance of 
being allocated to standard care.
A primary aim of the feasibility study was to determine 
whether the Postpartum Bonding Questionnaire (PBQ) 
should be retained as a primary outcome in the subse-
quent main trial. The PBQ is validated and widely used in 
the literature,39 but we wished to explore its acceptability 
and perceived relevance with mothers in the feasibility 
study. While the full results will be published separately, 
preliminary analysis from the Norwegian feasibility study 
revealed that the PBQ scored on relevant items, changed 
over time, and mothers expressed no particular objec-
tions to completing its items. Results from the feasibility 
study and discussion with parents in our UAG informed 
our decision to retain the PBQ as a primary outcome 
measure for the main study.
The feasibility study also enabled us to test logistical 
parameters related to postdischarge MT. We provided 
postdischarge sessions in the home setting, following 
advice from our UAG. Based on the results from feasi-
bility testing, we decided to adopt the following frequency 
in the main study to make consistency of sessions more 
feasible: two times during the first month following 
discharge from the NICU, and one time per month there-
after for a total period of 6 months.
trial procedures
After informed consent and baseline assessment, partic-
ipants will be randomly assigned to receive either MT 
plus standard care or standard care alone during their 
stay at the NICU. The intervention period will start imme-
diately following randomisation and will last until the 
infant’s initial discharge from hospital. Participants will 
be asked to complete the discharge assessments 1–2 days 
before discharge to home; for those who are unable to 
complete them before discharge, assessments will be valid 
if completed up to 2 weeks after discharge. On completion 
of discharge assessments, participants will be randomly allo-
cated to receive either postdischarge MT in home or munic-
ipal settings along with standard primary care, or standard 
primary care alone across a 6-month time period. Standard 
care may include other early intervention methods of care 
with the exception of other MT approaches. Participants 
are free to attend any type of treatment or therapeutic inter-
ventions in a postpartum setting, but they will be asked not 
to attend MT outside the study context through 12-month 
corrected age (CA; defined as chronological age reduced 
by number of weeks born before 40 weeks of gestation40). 
This time frame is sufficient because the hypotheses of the 
study concern the effects of early MT during NICU or post-
discharge; however, the receipt of any MT during the first 
24-month CA outside the study will be recorded. Outcomes 
will be assessed at several time points: at baseline; 1–2 days 
before discharge to home (end of MT during NICU); at 
6-month CA (end of postdischarge MT; primary endpoint); 
12-month and 24-month CA (figures 1 and 2). Treatment 
fidelity (adherence) will be evaluated by independent 
raters using audio and video recordings as described 
further below. The study has been designed in accordance 
with the SPIRIT 2013 statement (see online supplementary 
additional file 1). Ethical approval for the study has been 
granted by The Regional Committees for Medical and 
Health Research Ethics (2018/994/REK Nord) and supple-
mental ethical approval from each participating country 
was secured from relevant ethics committees in those coun-
tries prior to commencement of recruitment.
settings
To achieve the target sample size, it is necessary to recruit 
participants from multiple NICUs. Eligible NICUs are 
located in countries where the culture reflects what could 
be considered a ‘social support’ society, where parents are 
consistently present in the NICU. Eligible NICUs also need 
to have staff possessing the necessary scientific and clinical 
expertise to conduct the trial. Current partner sites are 
located across five countries in Europe, the Middle East 
and Latin America (Argentina, Colombia, Israel, Norway, 
Poland), and include eight NICUs (see trial registration 
data at  ClinicalTrials. gov for an updated list). The number 
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Figure 2 Schedule of enrolment, interventions and assessments. ASQ-3, Ages and Stages Questionnaire (third edition); 
ASQ:SE-2, Ages and Stages Questionnaire: Social-Emotional (second edition); Bayley-III, Bayley Scales of Infant and Toddler 
Development (third edition); CA, corrected age (chronological age reduced by number of weeks born preterm); EPDS, Edinburgh 
Postnatal Depression Scale; GAD-7, Generalised Anxiety Disorder Assessment; PBQ, Postpartum Bonding Questionnaire; PSS, 
Parental Stress Scale.
Eligibility criteria
Participants deemed eligible for the trial will meet the 
following criteria: Infants: born <35 weeks’ gestational 
age (GA), of both genders, any ethnicity, from single or 
multiple pregnancies, and whom the NICU clinical staff 
judges to be sufficiently medically stable to start MT, and 
to likely require longer than 2 weeks of hospitalisation 
from the time of recruitment. In multiple pregnancies, 
only the first-born infant who achieves medical stability 
will be included and randomised, while remaining 
siblings can receive the same interventions for ethical and 
practical reasons. Infant hearing screenings typically take 
place prior to discharge from the NICU, thus hearing 
status may not be known at time of study recruitment. 
Results of infant hearing screening at discharge will be 
tracked when available, to facilitate follow-up analysis, but 
infants who test positive for hearing impairments will still 
be included in data analysis due to the potential for infant 
and parent benefit despite such sensory impairment. 
Primary caregivers: one of the parents/caregivers must 
provide written, site-specific informed consent before any 
study procedures occur. Primary caregivers should agree 
to engage in at least 2 of the 3 MT sessions per week 
during NICU, and/or in 5 of the 7 MT postdischarge 
sessions. Primary caregivers should live within reasonable 
commuting distance from the treating NICU and should 
have sufficient understanding of the respective national 
language(s) to answer the questionnaires and participate 
in MT. Parents who are unable to complete the interven-
tion and/or questionnaires, for example, due to a mental 
illness, cognitive impairment and so on, will be excluded.
Interventions
The MT approach in this study is informed by models 
previously described and tested, including Creative 
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parents,26 41 42 First Sounds: Rhythm, Breath and 
Lullaby,31 43 44 and other developmentally appropriate and 
family centred approaches to MT with premature infants 
and their families.27 45 46 Like other MT models,41 42 it is 
based on the notion that infants have a capacity to commu-
nicate actively.47 48 As in some newer models, parents are 
highly involved and the therapeutic benefit is directed 
towards infant and parents alike.31 41 44 46 The approach 
here thus builds on an emerging consensus, but is more 
explicit in its adaptation to developmental levels and 
emphasis on infant–parent mutual regulation.49 Further-
more, unlike previous studies,38 MT is extended beyond 
the tertiary care setting to help with the transition to daily 
life and municipal care. MT focuses on supporting posi-
tive relationship formation within the infant–parent dyad 
by promoting beneficial mutual regulation, and includes 
psychotherapeutic support of the parents to promote 
their stabilisation, self-regulation, bonding and restor-
ative experience in alignment with trauma-preventive 
models.44 50 Key elements of the MT intervention appear 
in table 1.
MT during NICU
Participants will be offered individual MT sessions 3 
times/week for ~30–40 min/session, with a maximum of 
27 sessions per infant (assuming a maximum NICU stay 
of 9 weeks). Time spent in active music making with the 
infant may be shorter than 30 min, depending on infant 
readiness, and the remaining portion of the session will 
be devoted to providing psychotherapeutic support for 
parents and coaching them in how to use their voices 
therapeutically with their infants. MT will be provided 
for eligible infants once they achieve sufficient medical 
stability to begin MT, usually after 26 weeks’ postmen-
strual age (PMA; defined as GA at birth plus the time since 
birth40). Use of live music will follow recommendations 
from the American Academy of Pediatrics Committee on 
Environmental Health51 and the Consensus Committee on 
Recommended Design Standards for Advanced Neonatal 
Care,52 namely that noise levels within the NICU should 
remain <45 dB (A weighted), with hourly maximum sound 
levels (Lmax) <65 dBA, and no >10% of each hour (L10) 
>50 dBA. Prior to the first MT session with the infant, 
the music therapist will meet with the parents to discuss 
MT and assess aspects that will inform the course of MT 
including music preferences and history, cultural values 
related to music, level of comfort with singing, infant 
signals and patterns, family strengths and needs, and any 
challenges and resources that the parents deem relevant. 
The music therapist will then explain basic elements of 
the procedures listed below, engage parents in musical 
demonstration and form a loose plan for how the parents 
and music therapist will begin MT with the infant. The 
music therapist will observe the infant during a period of 
handling (such as during diaper change or transition to 
parent’s arms) in order to become more familiar with the 
infant’s signals and tolerance of stimulation, and parents’ 
modes of responding to the infant. Thereafter, a flexible 
protocol of procedures matched to infant PMA, familial/
cultural preferences and infant’s demonstrated readiness 
to receive stimulation, will occur as individually tailored 
MT sessions at bedside:
From ~26 to below 32 weeks’ PMA, cautious use of 
sung/toned voice will be the main focus. During MT, the 
infant may be held in a static manner by the caregiver 
(eg, skin-to-skin care), resting in his/her isolette with the 
portal door open, or resting in his/her basinet or bed. 
MT during skin-to-skin care will be encouraged, if skin-
to-skin care is part of standard care and the infant toler-
ates it. The music therapist assesses the infant’s needs and 
behaviour state, and if appropriate for the infant, shows 
caregivers how to use basic touch and positioning (such 
as caregiver/therapist’s hand lightly and statically placed 
on infant’s chest or back, or hands cupped at infant’s 
head and feet) and/or principles of facilitated tucking 
and midline alignment to promote physical containment, 
enable behaviour state regulation and prepare the infant 
for MT. Parents will hold their infant or provide basic 
touch and/or positioning, and will receive support or 
demonstration from the music therapist as needed. Using 
toning or predominantly wordless singing voice matched 
to infant breathing patterns, facial expressions and move-
ments,41 42 while monitoring infant behaviour state shifts 
and physiological responses, the music therapist demon-
strates how to either pacify the infant to promote sleep or 
bring the infant to a quiet alert state, depending on the 
infant’s needs. Specific pitches used may be matched to 
the pitch of infant vocalisations, if present, or selected to 
mask environmental noises, and will aim to be comfort-
ably within the parent’s vocal range.43 When appropriate 
for the infant, simple melodies or songs of kin31 43 modi-
fied into an infant-appropriate style are matched to infant 
breathing rate, gesticulations and facial expressions, and 
engagement/disengagement cues, so that the music 
remains infant-directed. Caregivers are encouraged to 
lead the singing/toning as soon as they feel comfortable, 
while the music therapist simultaneously provides musical 
and/or coaching support. MT may occur during breast-
feeding or other feeding attempts, if the parents desire it 
and the infant tolerates it, but MT will not occur during 
painful or sensorially demanding medical procedures 
due to the risk of over-stimulation.
From 32 weeks to below 36 PMA, the use of MT centres 
around cautious use of infant-directed music with expanded 
sensory experience. This phase applies as soon as the infant 
demonstrates readiness to receive additional sensory stim-
ulation, but not prior to 32 weeks’ PMA. Guidelines from 
the previous phase apply and are developed on in this 
phase for infants who are ready for more than pacification. 
Culturally relevant, caregiver-preferred songs are modi-
fied in an improvisatory manner by caregivers to match 
infant’s breathing rate, engagement/disengagement cues, 
facial expressions and gesticulations, in order to facilitate 
a musical interplay between caregiver and infant.41 42 This 
interplay generally moves from more pacifying in nature 
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Table 1 Key elements of the music therapy intervention
Phase of intervention Key elements Intervention description
All phases High parental/caregiver involvement and 
resource-oriented
Parents/caregivers are recognised as possessing inherent 
resources that can aid their infant and themselves 
following premature birth. In all aspects of the MT 
intervention, parents are encouraged to take a leading 
role, while receiving support from the music therapist.
Therapeutic benefit aimed at infant–
parent dyad/triad
MT promotes infant–parent mutual regulation and includes 
psychotherapeutic support of parents.
Neurodevelopmentally appropriate Specific use of MT is matched to infant PMA, familial/
cultural preferences and infant’s readiness.
Positioning to promote beneficial mutual 
regulation
Infant/parent positioning is considered a vital component 
for promoting beneficial self-regulation.
Based on needs of infant/parent(s) in the 
moment
Infant and family needs are assessed at the beginning of 
each intervention phase (during NICU and postdischarge), 
and during each MT session to assure that use of MT 
matches needs in the moment (eg, promoting sleep vs 
encouraging quiet alert interaction).
Parental voice as foundation for infant-
directed use of song
Parents’ use of their sung (and when necessary, spoken) 
voice along with positioning and physical presence 
forms the foundation of an attuned response to their 
infant. Parents’ sung voice, facial expressions and vocal 
expressions vary in response to infant’s engagement/
disengagement cues, breathing rate, gesticulations and 
facial expressions, so that the music remains infant-
directed.
Infant medically stable, 
in NICU, 26 to below 32 
weeks PMA
Cautious use of sung/toned voice Predominantly wordless singing voice is matched to infant 
breathing patterns, facial expressions and movements, 
and either promotes sleep or a quiet alert state depending 
on infant’s needs.
Incorporation of familiar songs adapted 
for the premature neonate
Parents learn how to adapt songs that are familiar/
preferred so that they are appropriate for the preterm 
neonate (eg, simplified and/or transformed into lullaby 
style).
Infant medically stable, 
in NICU, 32 wks to below 
36 weeks PMA*
Cautious use of infant-directed song 
with expanded sensory experience
Culturally relevant, caregiver-preferred songs are 
adapted in the moment to match infant breathing rate, 
engagement/disengagement cues, facial expressions 
and gesticulations, to promote musical interplay when 
appropriate for the infant. The musical interplay may 
include dynamic touch, and parents’ use of vocal inflection 
and phrasing to promote rudimentary musical dialogue, 
eye contact and social responses.
Addition of rhythmic cues and musical 
phrasing cues to support feeding 
attempts
By adapting familiar songs, rhythmic aspects of 
musical phrasing, and the addition of mildly stimulative 
vocal sounds can be matched to infant engagement/
disengagement cues to support suck-swallow-breathe 
coordination and promote mutual regulation.
Accompanying instruments are used to 
support the dyad/triad, with complexity 
matched to infant readiness
The music therapist may use acoustic instruments (eg, 
nylon string acoustic guitar, monochord) to provide single 
tones or simple accompaniment to support infant/parent, 
if infant tolerates the added musical stimuli well.
Infant medically stable, 
in NICU, from 36 weeks 
PMA
Expanded engagement in musical 
exchange
Parents adapt preferred songs so that vocal inflection and 
musical phrasing reflect infant responses and promote eye 
contact, vocalisation and rudimentary social interaction, 
if appropriate for the infant. Parents may also use their 
positioning while singing to promote auditory localisation, 
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Phase of intervention Key elements Intervention description
Postdischarge from 
NICU
Based on needs of infant/parent(s) in 
the moment and in relation to recent 
challenges
Infant and family needs are assessed at the beginning of 
each MT session, and particular strengths and challenges 
that have arisen in the last 2 weeks are identified and 
targeted (eg, transitioning between behaviour states, 
maintaining alertness during feeding, experiencing 
rewarding relation).
Expanded engagement in musical 
exchange, including adapted play 
songs, when appropriate
Parents engage in and expand on musical approaches 
from the previous phase, matched to infant/family needs, 
and music therapist models variations and adaptations as 
needed.
Identification of musical resources that 
may help address current challenges or 
build on current strengths
Parents and music therapist brainstorm how music can 
be adapted and used for infant/family needs, and parents 
have a chance to try out certain approaches with support, 
if appropriate.
*Elements of the prior phase apply to subsequent phases. An infant remains in the previous phase (despite PMA) until ready to receive more 
expanded stimulation. The combination of elements used within each phase will depend on the infant’s needs in the moment.
MT, music therapy; NICU, neonatal intensive care unit; PMA, postmenstrual age.
Table 1 Continued
weeks’ PMA. Musical interplay may include gentle dynamic 
touch to back of infant’s head or along infant’s back, 
depending on the infant’s tolerance. The musical interplay 
can be used to support the infant in a quiet alert state, if 
appropriate for the infant. Vocal inflection may be used to 
promote eye opening, eye contact and responses to social 
cues (eg, smiling, cooing). The infant-directed improvised 
interaction will be paced and modified according to infant 
responses and engagement cues, and will be reversed or 
paused in response to disengagement cues. Conversely, for 
infants who have difficultly rousing for meal times, sessions 
can begin as described in ‘cautious use of sung/toned 
voice’, with caregiver/therapist hand placed lightly and stat-
ically on infant’s chest or back, or both hands/wrists lightly 
and statically cradling the sides of the infant and supporting 
the infant to align at midline. If the infant tolerates 
infant-directed singing in these positions, the caregiver/
therapist can progress to include gentle rhythmic cues via 
light touch to coax the infant into a quiet alert state. If MT 
is used during breastfeeding attempts, rhythmic aspects of 
musical phrasing,53 and the addition of slightly stimulative 
vocal sounds can be matched to infant engagement/disen-
gagement cues to support suck-swallow-breathe coordina-
tion and promote infant-parent mutual regulation.54 The 
music therapist may use simple acoustic instruments (eg, 
nylon string acoustic guitar, monochord) with single tones 
or simple accompaniment to accompany infant/caregiver 
during this phase, if the infant tolerates such additional 
stimulation without disengagement cues or physiological 
signs of overstimulation.
From 36 weeks’ PMA, MT will focus on expanded 
engagement in musical exchange. This phase applies 
when the infant demonstrates readiness to engage in 
increasingly more interactive levels of musical exchange. 
Caregivers interact musically with the infant, using vocal 
inflection and musical phrasing to encourage the infant 
to achieve a quiet, alert state and engage in eye contact, 
vocalisation and rudimentary social interaction, if appro-
priate for the infant. Depending on infant readiness, 
caregivers may use their voices and physical positioning 
to promote auditory localisation, auditory tracking and 
eye contact; and their fingers and hands to promote 
reaching, grasping, and mouthing. The therapist will 
encourage the caregiver to adapt preferred lullabies and 
children’s songs or to modify songs of kin31 43 in order 
to encourage musical dialogue with the infant, and the 
therapist may provide basic harmonic or melodic accom-
paniment as support.
Standard care during NICU
This will vary across countries, but will typically include 
necessary medical care and a limited amount of interven-
tions to reduce stress among infants and to inform and 
promote safety in parents.55 Components of standard 
care will be recorded at each site.
MT postdischarge from hospital
Infant–parent dyads will be offered 45 min individual 
MT sessions, 7 times distributed across the first 6 months 
after discharge (2 times/month for the first month, and 
1 time/month thereafter). These will occur at home, 
municipal child health centres or follow-up clinics and 
comprise: (1) Verbal greeting and brief discussion of 
infant’s progress and parents’ related coping (~5 min). 
(2) Musical greeting of infant and caregiver, encour-
aging caregiver to participate (5 min). (3) Engagement 
in musical exchange following the procedures described 
in the ‘from 36 weeks’ category above and incorporating 
adapted play songs, with therapist modelling musical 
engagement (~10 min). (4) Discussion of current infant/
parent challenges and strategies for using musical inter-
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musical techniques to promote self-regulation or to facil-
itate musical interaction, depending on needs identified 
by the caregiver (~10 min). (5) Caregiver demonstration 
of techniques discussed during session (~10 min). (6) 
Musical closure and reminder of planned timing for next 
visit (~5 min). Any siblings may be involved if desired by 
the caregiver, and sessions will incorporate musical instru-
ments and resources present in the home, if appropriate 
for the infant. Subsequent sessions will follow a similar 
sequence, adjusted to infant developmental level and 
ongoing needs. The therapist will work in close dialogue 
with those providing standard aftercare procedures, when 
possible.
Standard care postdischarge from hospital
This includes follow-up visits and preventive interventions 
in primary or specialist healthcare as needed. Preventive 
interventions during the first year of life are focused on 
growth/eating/nourishment as well as psychomotor/
sensory development and also include a focus on fami-
lies and bonding.55 Standard care may include other early 
intervention methods of care with the exception of other 
MT approaches.
Training in study procedures
The site investigator at each site will maintain respon-
sibility for assuring that the trial procedures are imple-
mented as intended. Site investigators and music 
therapists received initial training on study procedures 
during an in-person, 3-day training in June 2018. In addi-
tion, site investigators, music therapists and other site 
research personnel received online follow-up training 
from core team members prior to the commencement of 
the study at their site. Music therapists will receive addi-
tional monitoring and feedback on their first two MT 
sessions from NICU phase and first session from post-
discharge phase, using review of audio/video recordings 
obtained for subsequent evaluation of treatment fidelity. 
The core team will maintain dialogue with each site at 
least monthly during implementation of the study to 
assure adherence to the protocol, answer questions and 
help problem-solve possible challenges.
Treatment guidelines for MT
MT during NICU and postdischarge phases are conducted 
in accordance with treatment guidelines established for 
this study. Guidelines are grounded in current evidence-
based practices, experiences from the Norwegian feasi-
bility study and feedback from our UAG and Scientific 
Advisory Committee (SAC). These treatment guidelines 
are used in training the music therapists involved in the 
study, and help promote consistency of treatment imple-
mentation across study sites. The treatment guidelines 
articulate guiding principles underlying the intervention, 
delineate the level of variation that is acceptable and 
provide illustrative examples of approaches. Implemen-
tation of the guidelines allows for individual tailoring 
to meet the needs of the infant and/or parents, and 
presumes a music therapist trained specifically in the use 
of MT for premature infants and their families. Treat-
ment guidelines will be available as a separate paper.
Assessment of treatment fidelity
We will assess treatment fidelity in terms of treatment 
delivery and treatment receipt. A predetermined selec-
tion of audio recordings from NICU MT sessions and 
video recordings from postdischarge MT sessions will be 
assessed for adherence to core elements of the interven-
tion. Extent of adherence during treatment delivery will 
be assessed by music therapists reviewing recordings of 
their sessions and completing self-ratings, and external 
raters reviewing the same recordings to determine extent 
of adherence. Inter-rater reliability between the external 
raters will be evaluated, and degree of correspondence 
between the external and therapist self-ratings will be 
determined, as appropriate. We will evaluate fidelity in 
regard to treatment receipt by parental self-rating at the 
6-month CA timepoint.
outcomes
Unless indicated otherwise, all outcomes will be assessed 
at baseline; 1–2 days before discharge to home; at 6-month 
CA (end of MT; primary endpoint); and at 12 months 
of CA (figures 1 and 2). All applicable outcomes (ie, all 
that are scale-based) will be calculated as final values, but 
where baseline scores are available they will be included 
in the statistical models (see below). Data collectors and 
assessors will be trained in assessment procedures and 
blinded to participant allocation; success of blinding will 
be verified. For all self-report instruments we will use 
official translations, or if not available, we will translate 
according to recommended procedures with translations, 
back-translation and discussions before the final version is 
completed.56 Psychometric properties of the instruments 
will be assessed across sites.
Primary outcome
Bonding between primary caregiver and infant at 
6-month CA will be measured using the PBQ57 58; the 
same outcome will also be assessed at baseline, discharge, 
and at 12-month CA. The PBQ is a parent-rated screening 
instrument for disorders of the early mother-infant 
relationship consisting of 25 statements on a 6-point 
Likert scale (each 0–5; sum score ranging from 0 to 125; 
high=problematic), addressing problems in the moth-
er–infant relationship based on weakened bonding; rejec-
tion and anger; anxiety about care; and risk of abuse.59 
The scale is validated and widely used in clinical prac-
tice and research.39 It has been translated and tested 
in several languages and cultures58 and has been found 
to be reliable in mothers with or without depression or 
bonding problems.59 Results from feasibility testing and 
user feedback in Norway confirmed the acceptability and 
relevance of the PBQ, also in comparison to alternative 
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scale covers both the more common and the rare but 
important problems that parents and infants can have.
Secondary infant outcomes will be as follows
1. The most important among the secondary outcomes 
is child development at 24 months of CA, as indicated by 
the Bayley Scales of Infant and Toddler Development, 
third edition (Bayley-III). The Bayley-III is consid-
ered the gold standard for assessing development in 
young children up to 42 months.60 At 24 months, the 
tool is used routinely in many countries for extreme-
ly premature infants. Assessors will be trained and 
reliability-tested before conducting the assessments 
for this study, also in cases where the assessments are 
part of routine procedures, when possible. The three 
main composite scores of the Bayley-III are cognitive, 
language (receptive and expressive) and motor (fine 
and gross motor) development; each of the scales is 
standardised with a population mean of 100 (SD 15), 
with higher scores indicating better development. 
No total score covering all domains is available, but 
the most important areas for the present study will be 
language and cognition. The Bayley-III has US norms 
and has been used extensively for developmental as-
sessments for premature infants (eg, Luttikhuizen 
dos Santos et al61).
2. Infant development at 6-month and 12-month CA will 
be assessed by the Ages and Stages Questionnaire, third 
edition (ASQ-3).62 63 The ASQ-3 is an age-specific par-
ent-reported screening questionnaire consisting of 30 
items covering five developmental domains with five 
subscales: communication, fine-motor, gross-motor, 
problem-solving and personal-social (possible range 
0–60) and a total score (possible range 0–300), with 
higher scores indicating better development.
3. Infant socioemotional development will be measured 
by the Ages and Stages Questionnaire: Social-Emo-
tional, second edition (ASQ:SE-2) at 6 and 12 months 
of CA. This is a parent-completed questionnaire with 
19 or 22 Likert-scaled items (each 0-5-10), plus addi-
tional items for whether an item is of concern to the 
parent (each 0–5), resulting in a score ranging from 
0 to 285 or 0 to 300, at 6 and 12 months, respectively. 
Lower scores indicate better socioemotional develop-
ment.64 65
4. Rehospitalisation during the first year of life (exclud-
ing outpatient visits), based on electronic health re-
cords or parent reports. This will be calculated as the 
time from initial discharge until first rehospitalisation.
Secondary parental outcomes include the following
1. Maternal depressive symptoms will be assessed with 
the Edinburgh Postnatal Depression Scale (EPDS) 
at baseline, 1–2 days prior to discharge, and at 6 and 
12 months of infant CA. The 10-item validated self-re-
port instrument assesses mothers’ postpartum de-
pressive symptoms, excluding somatic symptoms of 
depression that are common in new mothers (such as 
loss of energy, feeling tired, changes in appetite and 
sexual drive).66 Scores can range from 0 to 30, with 
high scores indicating more depressive symptoms.
2. Level of anxiety (both mothers and fathers) will be as-
sessed with the Generalised Anxiety Disorder Assess-
ment (GAD-7) at baseline, 1–2 days prior to discharge, 
and at 6 and 12 months of infant CA. The self-report 
7-item questionnaire serves as a screening tool and 
severity measure for generalised anxiety disorder.67 
Scores can range from 0 to 21, with higher scores indi-
cating higher anxiety.
3. Level of parental stress (both mothers and fathers) will 
be assessed with the Parental Stress Scale (PSS) at 6 
and 12 months of infant CA. This is a self-report 18-
item questionnaire that assesses stress associated with 
parenting.68 Scores can range from 18 to 90, with high-
er scores indicating higher stress.
Other measures
Specific medical and social factors relevant for subgroup 
analyses will include parents’ socioeconomic status 
(collected at baseline), infants’ hearing status (collected 
at discharge), frequency of skin-to-skin care during 
NICU, and experience of breastfeeding prior to 6-month 
CA. Additional open-ended questions will address other 
potential factors that might impact infant responsiveness 
(which may include, eg, intraventricular haemorrhage, 
metabolic disturbances, or genetic disorder among 
infants, and known mental health or substance use prob-
lems of parents). These will be drawn from hospital 
records and may be supplemented by parent self-reports.
Cost-effectiveness
We will explore and collect data necessary for analysing 
cost-effectiveness both from a health services perspec-
tive (ie, costs of all treatments incurred within the health 
sector including the costs of MT and standard care) and 
from the broader societal perspective (ie, including all 
treatments incurred by the health sector and other indi-
rect costs such as productivity losses and out-of-pocket 
expenses incurred by the parents). If clinical effectiveness 
is found, we will apply for separate funding to explore 
the additional cost to achieve a unit improvement in 
parent–infant bonding and explore the likelihood MT 
will be good value for money. This will be done through 
incremental cost-effectiveness ratios and willingness to 
pay analyses. Otherwise, these data will be used to describe 
the context in which the treatment took place.
Adverse events
All significant harms as well as unintended effects for 
each group will be collected and described by the site 
investigator, and reported to the core team. All adverse 
events that site investigators suspect may be related to MT 
and all serious adverse events will be reported to the Data 
and Safety Monitoring Committee (DSMC) by the core 
team. A special form to report trial-related adverse events 
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sample size and power calculation for the main comparison
No previous RCT examined effects of MT on the PBQ; 
two small RCTs38 and a recent non-randomised study46 
examined mother–infant bonding, but provided insuffi-
cient data for meta-analysis. Studies using the PBQ with 
other interventions found effects ranging widely from 
around 0.25 to 9.0, with SDs ranging from 4 to 12.11 69 70 
Assuming a difference of 4 points on the PBQ (SD=8) as 
a minimal clinically important difference for this study, 
power of 80% will be achieved for each main effect (each 
tested on a two-sided 2.5% significance level, ie, 5% with 
Bonferroni correction for two tests) with a sample size 
of 155. Taking into account some clustering by country 
(ICC 0.01; 5 countries), this is increased to 203. To allow 
for 20% attrition, we will aim to include 250 infants (~50 
in each country) and their parents. This sample size will 
also ensure power for testing proportion differences of 
about 15% (eg, binary analysis of problematic bonding; 
rehospitalisation).
Special considerations are needed for multiple preg-
nancies (twins, triplets and so on), which account for 
about 2% of all pregnancies in the Hordaland region of 
Norway,71 but are more commonly encountered in NICUs 
due to elevated risk of preterm birth. Although including 
all siblings would serve to increase the sample size, it may 
lower the resulting power due to cluster effects. There-
fore, we will only formally enrol and analyse the first-born 
sibling of each multiple pregnancy, although all multiples 
can receive the allocated intervention (see the Eligibility 
criteria section).
recruitment
Recruitment at the first site commenced in July 2018, 
and completion of recruitment is planned for the end 
of 2019. Enrolment will be completed in the NICU by a 
trained member of the unit staff according to the eligi-
bility criteria. The staff person will be responsible for first 
contact with caregivers, providing an opportunity for 
informed consent. We estimate that an 18-month period 
for recruitment will be sufficient to achieve the targeted 
sample size. Each site will be encouraged to recruit ~50 
infants and their parents; therefore, slow recruitment 
at some sites will be tolerable. Recruitment rates will be 
monitored carefully. Local and national partners respon-
sible for primary care provision will serve as contact points 
after discharge and will be actively involved, wherever 
possible. Once an infant is randomised, the site investi-
gator will make every reasonable effort to follow the infant 
and the parent/caregiver for the entire study period of 
24 months. The site investigator will be responsible for 
developing local standard operating procedures for the 
site, in order to facilitate implementation of all aspects of 
the study. In addition, site investigators will develop post-
recruitment retention strategies to promote retention (eg, 
development of a newsletter directed to participants).
randomisation and allocation concealment
After site-specific informed consent and baseline assess-
ment, participants will be randomly assigned to MT during 
NICU or standard care using a computer-generated rando-
misation list, with ratio 1:1, in blocks with sizes of 2 or 4 
varying randomly, stratified by site using an online system. 
The random allocation sequence will be generated and 
administered by people with no involvement in the clin-
ical work to ensure allocation concealment. One potential 
issue with providing MT in shared NICU rooms is contam-
ination. Parents may pick up strategies from other parents 
in the same room (or, likely to a lesser extent, from other 
parents or staff on the ward). We will assess contamination 
through the following questions at the end of each parent’s 
participation in the study: ‘How often did you sing or play 
music with or for your child (daily/weekly/occasionally/
never)? If so, in what way (please describe)? Did you learn 
from another parent in the NICU about using music (yes, 
please describe/no)?’
Before discharge to home, participants will be 
randomised a second time to postdischarge MT or stan-
dard care in a 1:1 ratio, using the same procedures. 
This two-step randomisation was chosen as the best way 
to create balance among those remaining in the study 
for the postdischarge phase, and to avoid differential 
drop-out in the NICU phase due to expectations for the 
postdischarge phase. We will assess potential contamina-
tion in the postdischarge phase by asking participants if 
they engaged in MT with their infant outside of the study 
during the first year of the infant’s life, and if so, the 
frequency and nature of such engagement.
blinding
Due to the nature of the intervention neither participants 
nor staff can be blinded to allocation, but are reminded not 
to disclose the participant’s allocation status to outcome 
assessors. All outcomes that are not self-reports will be 
conducted by an assessor blind to treatment allocation, and 
success of blinding will be tested by asking assessors.
data analyses
Baseline analysis
Sociodemographic and clinical baseline properties for 
the groups will be characterised by descriptive methods 
(mean (SD), median (range), n (%)).
Primary analysis
We will use an intention-to-treat approach using all avail-
able data from all participants as randomised, regardless 
of the intervention actually received. Multiple imputation 
will be used for missing data, if applicable.72
Effects will be examined by testing the randomised 
groups for differences in the primary endpoint (t-test or 
Mann-Whitney; change in PBQ scores to 6-month CA), as 
well as by fitting linear mixed models. In the first model-
ling step, we will assess the effect of the first randomisa-
tion (figure 1) using the following model:
 PBQit = β0 + β1 timet + β2 gri + β12 timet gri + Ui + εit, 
where PBQit denotes the PBQ score for participant i at 
measurement t, timet the time from baseline at measure-
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i. β0, β1, β2 and β12 are the coefficients estimated in the 
model, Ui is an individual random term per participant 
and εit an independent, identically distributed error 
term. In the second step, we refine the model to take 
into account both randomisation steps, leading to the 
extended model:
 
PBQit = β0 + β1 timet + β2grR1i + β12 timet grR1i+
β3 grR2i + β13 timet grR2i + U + εit,  
with the same notation as above and grR1i and grR2i 
denoting the groups from the first and second rando-
misation, respectively. In these models β1 describes a 
group-independent time effect, β2 and β3 a time-inde-
pendent group effect, and β12 and β13 the time-dependent 
change of the group effect. We will investigate both linear 
and simple contrasts (comparing each time point with 
the baseline) in time to assess the treatment effect.
Secondary analyses
The same analyses will be done for the secondary 
outcomes; using an analogous generalised linear mixed 
model for binary outcomes. Perprotocol analyses will 
include those who received at least 6 MT sessions in the 
NICU and at least 5 MT sessions postdischarge, respec-
tively; these are considered the minimum numbers for 
the intervention to be successful.
Subgroup analyses
Additionally, we will conduct exploratory statistical anal-
yses for prespecified subgroups: sex; GA at birth (<28, 
28 to <32, 32 to <35 weeks); hearing status at discharge 
(normal vs abnormal); bonding at baseline (PBQ 
impaired bonding score ≥11 vs <11); parental socioeco-
nomic status (poor vs other)73; average parental skin-to-
skin care during NICU (4 or more days per week vs fewer 
than 4 days per week); duration of breastfeeding prior 
to 6-month CA (none, fewer than 3 months, 3 months 
or greater); perceived emotional closeness during breast-
feeding (consistently, sometimes, rarely); as well as 
qualitative/mixed-methods analyses of process data to 
maximise learning.
data management and collection methods
In order to maintain participant confidentiality all infor-
mation will be stored with ID code numbers. The ID code 
numbers will be unrelated to participants’ identifiers, 
except in a central file with the participants’ contact 
details. All data will be stored on an electronic database 
management system located on a secure server with 
password-controlled access provided for research data 
collectors.
To ensure data quality, a trial database will be set up 
and maintained using a safe server (Uni Research Health 
Data Storage, UHEADS; now maintained by NORCE) 
and OpenClinica software. UHEADS is a system for safely 
storing health research data that accommodates the safe 
upload, storage and retrieval of any sensitive research 
data. OpenClinica is a web-based system for electronic 
data capture and clinical data management for multi-
centre clinical trials, which conforms to relevant interna-
tional standards for health research. NORCE Norwegian 
Research Centre AS runs an open source version of Open-
Clinica. A manual for using OpenClinica in this study 
has been created and distributed to collaborators. All 
records that contain names or other personal identifiers, 
such as informed consent forms, will be stored separately 
from study records identified by the ID code number. All 
study-related information on paper, including question-
naires, and administrative forms will be securely stored in 
locked file cabinets in areas with limited access.
data availability statement
After completion of the study period, de-identified indi-
vidual participant data of the main variables will be stored 
on a publicly available repository to ensure replicability 
and transparency, namely Norwegian Centre for Research 
Data (NSD).
Monitoring
The site investigators will practice entering data so that 
the core team can confirm that site investigators are 
proficient in all aspects of data entry, query response and 
communication with the team at each site. Uploaded data 
will be regularly checked by a core team researcher in 
order to ensure good quality data. Monitoring will follow 
a risk-based approach, with site investigators and core 
team members sharing the responsibility for quality and 
completeness of data. Core team members will conduct 
monitoring of source documents via scan of randomly 
chosen questionnaires at all enrolling LongSTEP sites, 
and will conduct on-site monitoring visits as needed. 
Through these on-site visits we will audit the overall quality 
and completeness of the data, examine source documents 
and interview coordinators to determine whether data 
reported in OpenClinica are complete and accurate, and 
whether the clinical site has complied with the require-
ments of the protocol. If a problem is identified, the core 
team will assist the site investigator in resolving the issues.
oversight, auditing and advisory committees
Data and Safety Monitoring Committee
An independent panel of three clinicians and method-
ologists with relevant expertise but no direct involve-
ment in the trial has been established to ensure research 
integrity and safety of participants in the trial. After an 
initial protocol review meeting, the DSMC will check the 
general progress of the clinical trial including recruit-
ment and completeness of follow-up; safety; and any other 
unforeseen events. To this end, the DSMC will receive 
updated reports from the project statistician, which 
may be unblinded with respect to intervention arms. 
Other project team members will not have access to such 
unblinded reports and will not attend the closed part of 
the DSMC meetings where such content is discussed. No 
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Trial Steering Committee
The Trial Steering Committee will consist of one repre-
sentative from each recruiting site, two user representa-
tives, and two representatives from the core team. It will 
monitor trial progress, will receive recommendations 
from the DSMC, and will be involved in all decisions 
about protocol amendments or other changes in the trial.
User Advisory Group
An advisory group consisting of parents of premature 
infants in Norway has been established for this study. 
This group is important for eliciting user feedback and 
ensuring relevance of the study, including any protocol 
amendments, as well as helping to ensure efficient recruit-
ment and dissemination strategies. Similar involvement 
of users in other countries will be encouraged.
Scientific Advisory Committee
An international group of clinicians and researchers with 
relevant clinical expertise was established during project 
development and will continue to advise on various 
aspects related to development and implementation of 
the study. The panel includes experts in areas such as MT, 
neonatology and psychology.
research ethics approval
The project as a whole received ethics approval from The 
Regional Committees for Medical and Health Research 
Ethics (2018/994/REK Nord, date of approval: 03 July 
2018). In addition, each participating site must secure 
local ethical approval prior to commencing recruitment. 
Site-specific written informed consent will be obtained 
postnatally following routine practices in the NICU. A 
trained staff of the trial will inform parents/caregivers 
about the study and provide an opportunity for informed 
consent. The parent/caregiver will receive written and 
oral explanation of the proposed research project, 
including information regarding the research project, 
the aims of the project, the duration of the participant’s 
involvement, the expected benefits to the participant and 
others, the nature of the intervention and the procedures 
involved in participation. It will be emphasised that enrol-
ment in the study is voluntary, that parents/caregivers 
can withdraw at any time from all or part of the study, and 
that any decision they take in this respect will have no 
bearing on the medical care received. Additionally, it will 
be highlighted that information generated by the study 
will be published, but that no details will be divulged from 
which the participant could be identified. Primary care-
givers will be informed of whom to contact in an emer-
gency, and the staff will be available to answer questions.
dissemination
Dissemination of the findings will apply to local, national 
and international levels. Aspects related to the feasibility 
of implementing MT in the hospital and in primary care 
and region-specific and culture-specific aspects of treat-
ment implementation will be submitted to corresponding 
specialised interdisciplinary journals. Main results of the 
trial concerning clinical effectiveness will be submitted to 
a leading medical journal. Additional results of explor-
atory statistical analyses and qualitative/mixed-methods 
analyses of process data will be published in specialised 
international journals. Beyond journal publications, we 
will disseminate results through presentations at national 
and international conferences. Popular dissemination, 
particularly to users, their families, user organisations, 
health services, and the general public will be achieved 
via a periodic newsletter, educational brochures and/or 
popular press articles.
dIsCussIon
Controlled research on the impact of MT for premature 
infants and their caregivers demonstrates short-term 
improvements in infant physiologic and behaviour states, 
feeding behaviour and length of hospital stay, as well as 
decreases in parental distress and anxiety.31 34 38 Long-
STEP fills a critical gap in knowledge by providing MT 
over a longer term from hospitalisation through the first 
6 months of life, and by assessing long-term outcomes of 
MT for both infant and parents during the first 2 years of 
the infant’s life.
Since MT for premature infants and their caregivers is 
an emerging area of practice and research within Scandi-
navia, this study aims to integrate best available evidence 
from international developments with standards of prac-
tice existing in specific national healthcare environments, 
to create a model of care that is culturally relevant for 
social support societies. LongSTEP consists of MT with 
a high level of parental engagement during the course 
of NICU hospitalisation and a support-to-parent and 
consult-to-parent model of MT for the first 6 months 
following discharge. The model enables parents to 
assume a central role in the care of their infant, with the 
music therapist providing support and coaching to help 
parents to use their innate resources to promote devel-
opmentally appropriate mutual regulation of the parent/
infant dyad, improve quality of interaction and enable 
healthy bonding during this vulnerable time. The long-
term aim is to assure healthy infant-parent relation and 
improve child developmental outcomes and promote 
parental psychological well-being over the first 2 years of 
the infant’s life.
The pragmatic nature of this trial and its high clin-
ical applicability are reflected in several dimensions, 
as described in the pragmatic-explanatory continuum 
indicator summary.74 Eligibility criteria are designed 
to be as inclusive as possible to promote applicability 
of the evidence with respect to a broad population. 
Broad inclusion criteria ensure enrolment of partic-
ipants with heterogeneous characteristics similar to 
those seen by clinicians in daily practice, and exclu-
sion criteria are narrow and exist only to ensure infant 
safety. Another pragmatic dimension of this trial is flex-
ible MT delivered by a qualified music therapist. MT is 
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incorporates family and cultural preferences. Addition-
ally, we do not restrict if or how cointerventions will be 
delivered. Participants in all arms will receive standard 
care. Analysis of primary outcome will include all indi-
viduals regardless of compliance in order to test if the 
intervention works under usual conditions, with all the 
noise inherent therein.
As a limitation it should be noted that our primary 
outcome measure is a self-report tool that is completed 
by parents who know which intervention they and their 
infant received. It is an inherent challenge within MT 
research that we cannot blind participants and providers, 
as they are aware that they have received MT. We believe 
that mothers’ subjective perception of their bond with 
their infant is an important phenomenon to evaluate and 
target with supportive intervention. We hope to offset 
the use of a self-report primary outcome completed by 
non-blinded participants by including the Bayley-III 
to provide an observational evaluation of infant devel-
opment completed by independent, blinded outcome 
assessors.
Clinical benefits as well as resulting societal benefits 
related to disability prevention and economic outcomes 
are likely to occur over a longer term. To address this, 
we will also include the possibility in the consent forms 
to collect later follow-up data, but these will be beyond 
the present project. In summary, this pragmatic trial will 
determine the effects of MT under usual conditions, and 
the design as a multicentre trial will further ensure wide 
generalisability.
The project’s social impact includes filling gaps in 
knowledge regarding the long-term impact of MT with 
preterm infants/caregivers, including highly user-rel-
evant outcomes. The high applicability of this trial will 
facilitate ongoing development of evidence-based care 
for preterm infants. Opportunities for improved training 
of music therapists and effective implementation of MT 
in neonatal care will apply both to countries where MT in 
this area is new and to countries that already have a more 
established foundation. Specifically, LongSTEP will make 
a unique contribution to continuity of care by bridging 
intervention from NICU hospitalisation to municipal 
and home settings postdischarge. In addition, LongSTEP 
fosters interdisciplinary collaboration between specialist 
and primary/municipal healthcare services (psycholo-
gists, nurses, physicians, music therapists).
In conclusion, LongSTEP builds off of evidence-based 
practice in neonatal MT, which supports the use of 
infant-specific MT tailored to developmental level and 
provided in conjunction with primary caregivers. The 
project will advance previous knowledge by suggesting a 
pathway by which MT can promote infant development 
while also improving parental psychological outcomes. 
Coaching parents in the use of music may help improve 
infant regulation and decrease parental stress during 
parent/infant interactions, which in turn may promote 
bonding and contribute to better infant developmental 
and parental psychological outcomes.
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